Javascript must be enabled to continue!
Terapi TB Paru Kasus Baru MTB Not Detected Disertai Peningkatan Fungsi Hati: Laporan Kasus
View through CrossRef
Tuberculosis (TB) is caused by Mycobacterium tuberculosis and can infect various organs, including the lungs and extrapulmonary. Standard treatment uses anti-TB drugs (OAT) such as rifampicin, isoniazid, ethambutol, and pyrazinamide, which can cause hepatotoxic side effects or Drug-Induced Liver Injury (DILI). This study aims to analyze the incidence of DILI in TB patients receiving OAT FDC therapy. The method used is a case study on a 24-year-old patient who experienced nausea, vomiting, and jaundice after receiving FDC therapy. Laboratory examinations showed increased ALT and AST, indicating DILI. Data were analyzed with periodic monitoring of liver enzymes and clinical changes. The results showed that temporary cessation of OAT and administration of hepatoprotective curcuma supplements were effective in improving liver function. This study suggests routine liver enzyme examination in patients receiving OAT therapy to prevent DILI. Alternative OAT therapy can be considered in patients with severe DILI.
Tuberkulosis (TBC) disebabkan oleh Mycobacterium tuberculosis dan dapat menginfeksi berbagai organ, termasuk paru dan ekstra paru. Pengobatan standar menggunakan obat anti-TBC (OAT) seperti rifampisin, isoniazid, ethambutol, dan pyrazinamid, yang dapat menyebabkan efek samping hepatotoksik atau Drug-Induced Liver Injury (DILI). Penelitian ini bertujuan untuk menganalisis kejadian DILI pada pasien TBC yang menerima terapi OAT FDC. Metode yang digunakan adalah studi kasus pada pasien berusia 24 tahun yang mengalami mual, muntah, dan ikterus setelah menerima terapi FDC. Pemeriksaan laboratorium menunjukkan peningkatan ALT dan AST, yang mengindikasikan DILI. Data dianalisis dengan pemantauan berkala enzim hati dan perubahan klinis. Hasil menunjukkan bahwa penghentian sementara OAT dan pemberian suplemen hepatoprotektor curcuma efektif dalam perbaikan fungsi hati. Penelitian ini menyarankan pemeriksaan rutin enzim hati pada pasien yang menerima terapi OAT untuk mencegah DILI. Alternatif terapi OAT dapat dipertimbangkan pada pasien dengan DILI berat.
University of Muhammadiyah Prof. Hamka (UHAMKA)
Title: Terapi TB Paru Kasus Baru MTB Not Detected Disertai Peningkatan Fungsi Hati: Laporan Kasus
Description:
Tuberculosis (TB) is caused by Mycobacterium tuberculosis and can infect various organs, including the lungs and extrapulmonary.
Standard treatment uses anti-TB drugs (OAT) such as rifampicin, isoniazid, ethambutol, and pyrazinamide, which can cause hepatotoxic side effects or Drug-Induced Liver Injury (DILI).
This study aims to analyze the incidence of DILI in TB patients receiving OAT FDC therapy.
The method used is a case study on a 24-year-old patient who experienced nausea, vomiting, and jaundice after receiving FDC therapy.
Laboratory examinations showed increased ALT and AST, indicating DILI.
Data were analyzed with periodic monitoring of liver enzymes and clinical changes.
The results showed that temporary cessation of OAT and administration of hepatoprotective curcuma supplements were effective in improving liver function.
This study suggests routine liver enzyme examination in patients receiving OAT therapy to prevent DILI.
Alternative OAT therapy can be considered in patients with severe DILI.
Tuberkulosis (TBC) disebabkan oleh Mycobacterium tuberculosis dan dapat menginfeksi berbagai organ, termasuk paru dan ekstra paru.
Pengobatan standar menggunakan obat anti-TBC (OAT) seperti rifampisin, isoniazid, ethambutol, dan pyrazinamid, yang dapat menyebabkan efek samping hepatotoksik atau Drug-Induced Liver Injury (DILI).
Penelitian ini bertujuan untuk menganalisis kejadian DILI pada pasien TBC yang menerima terapi OAT FDC.
Metode yang digunakan adalah studi kasus pada pasien berusia 24 tahun yang mengalami mual, muntah, dan ikterus setelah menerima terapi FDC.
Pemeriksaan laboratorium menunjukkan peningkatan ALT dan AST, yang mengindikasikan DILI.
Data dianalisis dengan pemantauan berkala enzim hati dan perubahan klinis.
Hasil menunjukkan bahwa penghentian sementara OAT dan pemberian suplemen hepatoprotektor curcuma efektif dalam perbaikan fungsi hati.
Penelitian ini menyarankan pemeriksaan rutin enzim hati pada pasien yang menerima terapi OAT untuk mencegah DILI.
Alternatif terapi OAT dapat dipertimbangkan pada pasien dengan DILI berat.
Related Results
Evaluasi sensitivitas dan spesifisitas Xpert MTB RIF dan Xpert MTB RIF Ultra pada berbagai spesimen untuk mendiagnosis tuberkulosis ekstra paru: Sebuah telaah literatur sistematis
Evaluasi sensitivitas dan spesifisitas Xpert MTB RIF dan Xpert MTB RIF Ultra pada berbagai spesimen untuk mendiagnosis tuberkulosis ekstra paru: Sebuah telaah literatur sistematis
Background: Molecular examination using Xpert MTB RIF and Xpert MTB RIF Ultra was introduced by WHO in 2010 as a fast and practical supporting examination in detecting Mycobacteriu...
Survival and infectivity of mycobacterium tuberculosis after aerosolization
Survival and infectivity of mycobacterium tuberculosis after aerosolization
<p dir="ltr">Tuberculosis (TB) remains the leading cause of death by a single infectious organism with over 1.3 million people succumbing to the disease every year. Despite e...
FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review
FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review
FAKTOR-FAKTOR YANG MEMPENGARUHI MORTALITAS PADA PASIEN DENGAN FRAKTUR COSTA: Literature Review Anna Tri Wahyuni1), Masfuri2), Liya Arista3)1,2,3 Fakultas Ilmu Keperawatan Univers...
Mathematical modeling suggests heterogeneous replication of
Mycobacterium tuberculosis
in rabbits
Mathematical modeling suggests heterogeneous replication of
Mycobacterium tuberculosis
in rabbits
Abstract
Tuberculosis (
TB
), the disease caused by
Mycobacterium tuberculosis
...
Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
Comparison of tests done, and Tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
Abstract
Background
Uganda introduced Xpert® MTB/RIF assay into its TB diagnostic algorithm in January 2012. In July 2018, this...
PENYULUHAN FAKTOR RISIKO TB PARU DI DESA CIKUNIR KECAMATAN SINGAPARNA KABUPATEN TASIKMALAYA TAHUN 2017
PENYULUHAN FAKTOR RISIKO TB PARU DI DESA CIKUNIR KECAMATAN SINGAPARNA KABUPATEN TASIKMALAYA TAHUN 2017
Tuberkulosis Paru (TB) paru merupakan penyakit kronis dengan agent Mycobacterium tuberculosis yang terus mengalami peningkatan kasus karena penularannya dari droplet penderita mela...
Diagnostic accuracy of swab-based molecular tests for tuberculosis using novel near point-of-care platforms: A multi-country evaluation
Diagnostic accuracy of swab-based molecular tests for tuberculosis using novel near point-of-care platforms: A multi-country evaluation
SummaryBackgroundSwab-based molecular platforms that enable testing of both sputum (via swabs swirled in sputum) and tongue swabs are emerging as a promising option for more access...
Early Assessment of Lymphoma Therapeutic Efficacy Via a Blood-Based Multi-Omics Test
Early Assessment of Lymphoma Therapeutic Efficacy Via a Blood-Based Multi-Omics Test
Introduction: Lymphoma is a heterogeneous group of hematological malignancies originating from the clonal proliferation of lymphocytes. Periodic functional imaging examinations are...

